Dispatch Bio, co-founded by Carl June, MD, the Richard W. Vague Professor in Immunotherapy at Penn Medicine, is developing a universal cancer treatment for solid tumors using its Flare™ platform with the goal of addressing two major challenges – the lack of tumor specific targets and the presence of an immune-suppressive tumor environment. Read more here.